MedTrace Logo

Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks

NCT05007730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-12-18

No results posted yet for this study

Summary

Malnutrition significantly contributes to the disability and mortality associated with Alzheimer's disease and Alzheimer's disease-related dementias. Thus, nutritional status is one important, modifiable clinical factor for maintaining physical and cognitive health among persons with dementia (PWD). This project will pilot an innovative approach to enhancing nutrition through the use of transitional-state snack supplements, or foods that start as one texture and change to another.

Specifically, this study aims to demonstrate the feasibility, acceptability, and safety of a transitional-state therapeutic nutrition supplement among adults with dementia. The central hypothesis is that access to ready-made, savory, nutrient- dense snack supplements that resemble "typical" preferred foods and eating habits will result in improved nutritional intake and status among PWD.

Conditions

Interventions

DIETARY_SUPPLEMENT

Transitional-state food therapeutic nutrition supplement

Participants will consume at least one "snack-sized" package of the transitional-state food supplements per day across the intervention trial.

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • Oregon Partnership for Alzheimer's Research

    collaborator UNKNOWN

  • University of Oregon

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2025-11-03
Completion
2025-11-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05007730 on ClinicalTrials.gov